Mylan (MYL) accused of Medicaid fraud by West Virginia over EpiPen - Bloomberg

September 20, 2016 10:52 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Mylan (NASDAQ: MYL) accused of Medicaid fraud by West Virginia over EpiPen, according to Bloomberg. The copmany was accused of inflating EpiPen prices by 500 percent.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Litigation, Trader Talk

Add Your Comment